Drug class
Topical non-steroidal anti-inflammatory drug (NSAID); biphenylacetic acid derivative
Mechanism of action
Inhibits cyclo-oxygenase-mediated prostaglandin synthesis in treated tissues, reducing local inflammatory pain and swelling.
General use cases
- Topical symptomatic treatment of musculoskeletal pain and inflammation, including sprains, strains, bruises and localised osteoarthritis, using authorised gel or patch formulations
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
